4-(3-(1-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-3-METHYL-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-7-YL)-4,4-DIMETHYL-5-OXO-2-THIOXOIMIDAZOLIDIN-1-YL)-2-(TRIFLUOROMETHYL)BENZONITRILE
UNII DL8DJ99XBS
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(3-(1-(4-cyano-3-(trifluoromethyl)phenyl)-3-methyl-4-oxo-2-thioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DL8DJ99XBS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2810090-73-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C30H18F6N6O2S2 SVYXCONIKAIQDV-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(3-(1-(4-cyano-3-(trifluoromethyl)phenyl)-3-methyl-4-oxo-2-thioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.